×

Get the Free Prostate Cancer Patient Guide. Enter your email to get the pdf.

Please leave this field empty

Go here to learn more or to get a mailed copy.

08/09/2016

Emerging Therapies

In labs around the world, researchers are busy identifying new drugs and treatment approaches that might prove beneficial to men with prostate cancer. Most of these investigational agents are being tested in men with advanced prostate cancer: therapy options for men at this stage of disease may not be effective. Read More

10/24/2015

Challenge Awards-Class of 2015

2015-2017 Movember Foundation-PCF Challenge Award ($1 Million) Project Title: Targeting the MLL Complex for the Development of New Therapeutics for CRPC   Principal Investigator: Shaomeng Wang, PhD (University of Michigan) & Arul Chinnaiyan, MD, PhD (University of Michigan) Co-investigators: Rohit Malik, PhD (University of Michigan), Angelo Anguilar, PhD (University of. Read More

10/24/2014

Young Investigator Award-Class of 2014

The PCF Young Investigator Award-Class of 2014 recipients are: 2014 Clay and Lynn Hamlin-PCF Young Investigator W. Nathaniel Brennen, PhD The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Mentors: John Isaacs, PhD, Charles Drake, MD, PhD Proposal Title: T cells Engineered to Selectively Deliver a PSA-activated Protoxin to Sites. Read More

10/24/2014

Challenge Awards-Class of 2014

MOVEMBER-PCF CHALLENGE AWARDS Movember-PCF Challenge Award ($1 Million) Project Title: Periprostatic adipose inflammation: A targetable mediator of prostate cancer progression Principal Investigator: Andrew Dannenberg, MD (Weill Cornell Medical College) Co-investigators: Kotha Subbaramaiah, PhD (Weill Cornell Medical College), Xi Kathy Zhou, PhD (Weill Cornell Medical College), Howard Scher, MD (Memorial Sloan. Read More

10/24/2013

Young Investigator Award-Class of 2013

The PCF Young Investigator Award-Class of 2013 recipients are: 2013 Steve Wynn-PCF Young Investigator Emmanuel Antonarakis, MD Johns Hopkins University School of Medicine Mentors: Michael Carducci, MD and Jun Luo, PhD Project Title: Understanding mechanisms of response and resistance to abiraterone (Zytiga) and enzalutamide (Xtandi) in men with metastatic castration-resistant. Read More

10/24/2013

Challenge Awards-Class of 2013

MOVEMBER-PCF CHALLENGE AWARDS, 2013 2013-2015 Movember-PCF Challenge Award ($1 Million) Project Title: Co-targeting the Cell Cycle and Androgen Signaling Axis via CDK4/6 Inhibition and Androgen Deprivation: A Novel Paradigm for treating Metastatic Hormone-sensitive Prostate cancer Principal Investigator: Maha Hussain, MD (University of Michigan) Co-investigators: Felix Feng, MD (University of Michigan),. Read More

10/24/2012

Challenge Awards-Class of 2012

PCF selected the 9 2012 Challenge Awards out of 96 proposals from highly-qualified research teams at 70 prestigious cancer centers spanning 10 countries across the globe. Following an extensive peer review, consisting of an external advisory board, PCF selected the top research proposals for funding. These projects represent a range. Read More

10/24/2011

Challenge Awards-Class of 2011

PCF vetted the 10 2011 Challenge Awards from a field of 59 research proposals from highly-qualified research teams at prestigious cancer centers around the globe. Following an extensive peer review, consisting of an external advisory board, PCF selected the top research proposals for funding. These projects represent a range of. Read More

10/24/2008

Young Investigator Award Recipients—Class of 2008 (The Inaugural Class)

The PCF's Young Investigator awards are inspired by Donald S. Coffey, PhD, prostate cancer research director at Johns Hopkins for 40 years. He has mentored more than 50 scientists and physician-scientists and trained more than 30 of today's leading prostate cancer researchers. These awards provide career and project support for. Read More

10/24/2008

Challenge Awards-Class of 2008

Translational research experts rigorously reviewed a wealth of proposals so PCF could provide Challenge Award funds to the top nine teams in less than 100 days. The Challenge Awards-Class of 2008, selected in nine categories of scientific investigation, are:   1. Progression Biomarkers Lead Investigator: Dr. Daniel Haber, Massachusetts General Hospital Project. Read More